Why Thousands of Women Have Stopped Paying $1,200 a Month for Ozempic — And What They're Using Instead

If you've been looking at Ozempic or Mounjaro, you already know the problem. Your doctor thinks it's a good option. Your insurance disagrees. And without coverage, the monthly cost — often $900 to $1,300 — is simply not realistic for most people.

This is not a fringe experience. Millions of women have been caught in the same loop: GLP-1 medications are clinically proven to reduce body weight by 15–20%, but accessing them has become a bureaucratic and financial obstacle course.

What most women don't hear about from their primary care provider is the legal, physician-prescribed alternative that's been available for years: compounded tirzepatide.

Compounded tirzepatide uses the same active molecule as Mounjaro and Zepbound — a GLP-1/GIP dual agonist — but is produced at FDA-regulated compounding pharmacies and prescribed directly by licensed telehealth providers. It is not a generic. It is not an off-brand substitute. It is the same mechanism, prescribed by a real licensed physician, made in a regulated facility, and shipped directly to your door.

The telehealth platform where women are accessing this has served over 50,000 patients, holds LegitScript verification, is HIPAA compliant, and offers free expedited shipping. The assessment takes 60 seconds online. A licensed provider reviews your profile and, if you qualify, writes the prescription. You cancel anytime.

If you've been paying full price out of pocket, or walking away from a prescription your doctor recommended because the cost doesn't make sense — this is what the alternative looks like. No clinic visit. No insurance battle. $1,120 less per month.